Intermediation service activities for specialised retail sale
ABIOSA PHARMA AS
Revenue 2025
NOK 0
Operating profit
NOK −491
Equity
NOK −12,000
Incorporated
2017
Share capital
NOK 30,000
Roles
Styrets lederKjell Hans Bakke
StyremedlemHenning Bakke
StyremedlemEdita Bakke
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| BAKKE CONSULTING AS | 45.0% | 135.000000 | 2025 |
| HENNING BAKKE | 22.7% | 68.000000 | 2025 |
| Edita Bakke | 22.3% | 67.000000 | 2025 |
| KJELL HANS BAKKE | 10.0% | 30.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.